-
Intermittent Fasting & Glycemic Control
JAMA Network Open recently published results of a randomized, open-label, active parallel-controlled clinical trial comparing an intermittent fasting program to both metformin and empagliflozin in Chinese adults with early type 2 diabetes. Known as the EARLY (Exploration of Treatment of Newly Diagnosed Overweight/Obese Type 2 Diabetes Mellitus) study, 405 participants were randomized in a 1:1:1…
-
Intermittent Fasting 101
There’s currently a lot of hype surrounding intermittent fasting (IF) – everyone in the health space seems to be talking about it. Raising a lot of questions and misconceptions, but the truth is – giving the body time to heal is critical for overall health and wellbeing. While IF is concerned with when you eat,…
-
New Paper Exposes Science Behind Intermittent Fasting
With the new year come new resolutions that oftentimes involve losing weight. Perhaps intermittent fasting is on the 2020 agenda.